Discontinuation

The Lowest Effective Dose: Finding Your Personal Maintenance Number

Every man's maintenance dose is different. Finding yours — the lowest amount that holds your weight without unnecessary side effects or cost — is a specific titration problem worth solving carefully rather than guessing at. Here's the protocol.

Published April 2026 · 8-minute read · Optimization protocol

You got to your goal weight on semaglutide 1.7 mg. You've been holding steady for 4 months. You're ready to think about maintenance. The question: what's the lowest dose that actually keeps you at this weight? Not the manufacturer's recommendation. Not what your buddy takes. Not what you read on Reddit. Your specific number.

Maintenance dosing is an underdiscussed precision problem. Too high and you're paying for drug you don't need, eating side effects you don't need, and losing more weight than you want. Too low and you regain slowly — often without realizing it until you're 8 lbs up and starting to worry.

Finding your personal minimum effective dose is worth doing deliberately. Here's the protocol.

Why there's no universal maintenance dose

Individual response to GLP-1s varies across a roughly 5–10x range for equivalent effect. The variables:

The FDA labels are calibrated for average effect across trial populations. Your number may be well below or above that. Finding it requires testing.

0.25–2.0 mg
Typical range of effective maintenance semaglutide doses across individual men — an 8x range that the FDA-labeled "maintenance = 2.4 mg" doesn't capture

The protocol

Finding your minimum effective dose is a stepwise reduction protocol with clear signals to continue vs. hold at each level.

The Minimum Effective Dose Finder

  1. Establish baseline stability. You should be at your target weight for at least 8 weeks on your current dose, with stable habits, before starting the finder protocol.
  2. Set your target weight range. Not a single number. Something like "185–189 lbs acceptable; 190+ is action threshold." Allow for water weight, meal timing, daily fluctuation.
  3. Step down one dose level. E.g., 1.7 mg → 1.0 mg (or 2.4 → 1.7; the standard label increments).
  4. Hold 8 weeks at new dose. Don't adjust before 8 weeks. You need the body to reach steady state and your habits to demonstrate holding power at this level.
  5. Assess against criteria. At 8 weeks: weight within target range? Food noise still manageable? Habits holding without struggle? If yes, step down again.
  6. Continue stepping down until you hit hold point. This is the dose where weight starts creeping up or food noise becomes intrusive enough that you're struggling with habits.
  7. Step back up one level. Your minimum effective dose is the level above your first regain signal.
  8. Confirm at that dose for 3 months. If weight holds, you've found your maintenance number.

Practical example: 46-year-old, 60 lbs lost on tirzepatide

MonthDoseWeight trendDecision
1–8 (active loss)Titrated to 10 mgLost 60 lbsReached goal
9–12 (stability)10 mgStable at goalStart reduction
13–147.5 mgStableStep down
15–165.0 mgStableStep down
17–182.5 mgStable but food noise upHold one more cycle
19–202.5 mg+3 lbs, noise manageableEvaluate
21+5.0 mg (step back)Returned to stable goalMED = 5 mg tirzepatide

This man's minimum effective dose for maintenance is 5 mg tirzepatide weekly. Not 10 mg (overkill). Not 2.5 mg (inadequate). The specific number that holds his specific biology and habits.

The four signals at each step-down

At each dose level, you're watching for four specific indicators:

Signal 1: Weight trend (most objective)

Signal 2: Food noise (most useful subjective)

Signal 3: Habit adherence

Signal 4: Body composition (quarterly check)

The time it takes

Running the protocol properly takes 6–12 months from initial step-down to confirmed minimum effective dose. This is not fast. But the cost of getting it wrong — either overmedicating for years or silently regaining — is higher than the cost of patience.

Skip this protocol and pick a maintenance dose by default (usually what the doctor suggests or what Reddit recommends) and you end up with a good-enough guess rather than your actual number. Fine for most purposes; suboptimal for men who want to optimize.

Common MED outcomes by starting dose

Rough patterns (not prescriptions) based on clinical experience:

A general pattern: your maintenance dose is typically one-third to one-half of the dose at which you achieved goal weight. Your specific number may differ.

When to step up again

Your MED is not a permanent number. Circumstances change, biology shifts, seasons pass. Situations when you might need to temporarily step up:

Thinking of your dose as dynamic — titratable up or down based on life circumstances — is more realistic than treating it as a fixed number forever.

What's suboptimal about starting too low

The "slowly boiled frog" pattern: some men skip the structured protocol and drop to the lowest available dose (0.25 mg semaglutide or 2.5 mg tirzepatide) immediately after reaching goal weight. Weight trends up 0.5–1 lb per month — too slow to trigger alarm, too consistent to be noise. Six months later they've regained 6 lbs; twelve months later, 15 lbs. By the time they notice, they're halfway back. Finding MED by too-aggressive step-down is worse than finding it by careful titration.

Bloodwork as confirmation

Once you've found your MED, confirm the metabolic picture is holding with quarterly labs during the first year:

If numbers are stable at your MED, you've solved the problem. If numbers are drifting (rising HbA1c, rising CRP, declining testosterone), your weight maintenance may be superficial while underlying metabolic state is eroding. Step up dose, tighten habits, or both.

The compounded vial option for fine precision

Standard GLP-1 pens deliver in fixed increments (0.25, 0.5, 1.0, 1.7, 2.4 mg for semaglutide). This is fine for most men but limits fine-tuning. If your MED is 0.35 mg, you'll end up either at 0.25 (possibly inadequate) or 0.5 (possibly excess).

Compounded vials with insulin syringes allow precise custom dosing. Drawbacks include shifting regulatory status for compounded GLP-1s since FDA shortage resolutions and the need for reliable sterile compounding sources. Work with a compliant telehealth provider rather than off-platform sources.

When to stop tinkering

At some point, stop optimizing. Once you've found a dose that:

...stop adjusting. The incremental gain from shaving another 0.1 mg off a dose is rarely worth the time and monitoring energy. Men who keep tweaking often end up undermedicated and regaining.

MED protocols need real prescriber support

Finding your minimum effective dose requires a physician willing to engage with flexible dose adjustments based on your specific response — not every telehealth platform handles this well.

Check Synergy Rx Eligibility → Synergy Rx offers physician-led GLP-1 programs that support MED finding and flexible dosing. Prefer brand-name FDA-approved for consistent documentation? Sesame Care via licensed US physicians. Want results-guaranteed programs? SHED.

The bottom line

Your minimum effective maintenance dose is a specific number. It's probably lower than your weight-loss dose and higher than the lowest available dose. Finding it requires patience — stepwise reductions of 8 weeks each, careful monitoring of weight, food noise, habits, and labs.

The process takes 6–12 months to complete. The payoff is an indefinite maintenance protocol at the lowest cost, lowest side-effect profile, and sustainable dose that's actually yours.

Skip the protocol and you'll either overmedicate (paying and tolerating more than needed) or slip toward regain without noticing. Run the protocol and you find the exact amount of support your biology actually needs.

This is a one-time project that produces a lifelong answer. Worth the months it takes to solve properly.

Affiliate disclosure: This article contains affiliate links. GLP-1 Men may earn a commission when you sign up through our links at no additional cost to you. Dose adjustment protocols should always be directed by a prescribing physician.

References

  1. Wilding JPH et al. STEP 1 extension weight regain data. Diabetes Obes Metab, 2022.
  2. Rubino D et al. STEP 4 trial. JAMA, 2021.
  3. Standard obesity medicine guidance on individualized pharmacotherapy dosing.